Keywords: genzyme, fined, l6, 8m, over, market, abuse
Genzyme fined L6.8M over market abuse regarding Cerezyme in the UK
Article | 07 April 2003
The UK subsidiary of US biotechnology major Genzyme has been fined L6.8million ($10.7 million) by the Office of Fair Trading ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
